Current Trends in Leukemia, Lymphoma, and Myeloma (CTLLM Kansas City)
|Event Date/Time: Feb 05, 2011||End Date/Time: Feb 05, 2011|
Overview and Purpose
This symposium is designed to update medical oncologists/hematologists and other health care professionals on potentially practice-changing data on the treatment of leukemia, lymphoma, and myeloma presented at recent international hematology/oncology meetings. Participants will have the opportunity to learn about these advances through presentations by national and regional experts, interactive case discussions, and question-and-answer opportunities, with the overall goal of integrating these advances into clinical practice as well as enhancing awareness of novel agents in development. Furthermore, the most important data will be presented in the form of a poster session, for which ample time will be allocated for viewing. These features will reinforce the key data and allow participants to see and hear the information in multiple formats. This program will thus provide an invaluable and timely opportunity for practicing oncologists/hematologists to increase their knowledge base and improve their performance in managing their patients. These meetings will also foster networking opportunities for community practitioners.
New for 2011: Poster session featuring top abstracts from ASH 2010!
This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies are also invited to attend.
At the conclusion of this symposium, you should be able to:
Discuss and debate emerging data on and recent advances in the treatment of patients with hematologic malignancies and integrate key findings into clinical practice